Arkadios Wealth Advisors Buys 1,229 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Arkadios Wealth Advisors raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,533 shares of the medical equipment provider's stock after acquiring an additional 1,229 shares during the period. Arkadios Wealth Advisors' holdings in Intuitive Surgical were worth $7,586,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC grew its holdings in shares of Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock worth $2,349,441,000 after purchasing an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co. increased its stake in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock valued at $1,890,676,000 after buying an additional 24,183 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James lifted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. Robert W. Baird increased their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research note on Thursday, October 17th. Finally, Mizuho raised their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $554.17.

Insider Activity

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last 90 days. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 1.5 %

ISRG traded up $8.56 during trading on Friday, hitting $592.64. 2,630,118 shares of the company's stock were exchanged, compared to its average volume of 1,158,623. The stock has a market cap of $211.09 billion, a P/E ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. The business's 50 day moving average is $540.66 and its two-hundred day moving average is $499.19. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.